Prognostic comparison between superior and basal segments in pure-solid non-small cell lung cancer
Shinji Yuhara1, Masaaki Nagano1, Yue Cong1
1Department of Thoracic Surgery, The University of Tokyo Graduate School of Medicine, 7-3-1, Hongo Bunkyo-ku, Tokyo, Japan.
General Thoracic and Cardiovascular Surgery
|September 19, 2025
Summary
Survival rates for non-small cell lung cancer in the S6 segment were similar to basal segments after lobectomy. Pure-solid tumors in either location did not show significant survival differences.
Area of Science:
- Thoracic Surgery
- Oncology
- Pulmonary Medicine
Background:
- Non-small cell lung cancer (NSCLC) in the superior segment (S6) may impact lymphatic drainage differently than basal segment tumors.
- Pure-solid NSCLC subtypes exhibit higher rates of lymph node metastasis and poorer prognoses.
Purpose of the Study:
- To compare survival outcomes between S6 and basal segment pure-solid NSCLC after lobectomy.
- To investigate the prognostic impact of tumor location within the lower lobe for pure-solid NSCLC.
Main Methods:
- Retrospective review of 157 patients with pure-solid, clinical N0 M0, ≤5-cm lower-lobe NSCLC.
- Patients underwent lobectomy with hilar and mediastinal lymphadenectomy.
- Analysis of overall survival, recurrence-free survival, and clinicopathological characteristics.
Main Results:
- No significant differences in 5-year overall survival (66.4% vs. 68.6%) or recurrence-free survival (54.8% vs. 65.5%) between S6 and basal segment groups.
- Tumor location was not a significant predictor of survival in multivariable analysis.
- S6 tumors showed a higher incidence of visceral pleural invasion; superior mediastinal lymph node metastasis occurred exclusively in two S6 cases.
Conclusions:
- Lobectomy with lymphadenectomy yields comparable survival for pure-solid NSCLC in S6 and basal segments.
- Tumor location within the lower lobe does not significantly affect survival for this specific NSCLC subtype.
- While S6 tumors may have a higher risk of visceral pleural invasion, survival outcomes remain similar post-surgical resection.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.9K
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.6K
